Malabsorption is characterized by the inability to digest or absorb nutrients from the small intestine into the bloodstream and is related to diseases of the pancreas, liver or intestine.
Pathophysiology
Nutrient digestion and absorption occurs in three phases
Luminal phase – breakdown and solubilization of proteins, carbohydrates, and fats by digestive enzymes and bile
Mucosal phase – transport of digested nutrients into gastrointestinal epithelial cells
Transport phase – transport of nutrients via lymphatics and portal circulation from small intestine to other parts of the body
Any process that disrupts one or more of these phases can cause malabsorption
Causes of malabsorption include:
Inadequate digestion of nutrients
Deficiencies of pancreatic enzymes (eg, chronic pancreatitis, carcinoma of pancreas, cystic fibrosis).
Impaired synthesis or secretion of bile (eg, biliary obstruction, cirrhosis)
Deconjugation of bile salts (eg, blind-loop syndrome)
Inadequate absorption of nutrients
Shortened bowel or loss of absorptive surface (eg, ulcerative colitis, Crohn disease, gluten-sensitive enteropathy [Celiac sprue], tropical sprue, lymphoma, surgical loss of functional bowel, blind-loop syndrome and hormonal disorders)
Impaired nutrient metabolism (eg, deficiency of intestinal disaccharidases)
Nutrient-specific transport deficiencies (eg, Hartnup disease)
Decreased availability of specific nutrients (eg, decreased vitamin B12 due to decreased intrinsic factor)
Increased neutral fats suggest a deficiency of pancreatic enzymes; increased split fats suggest impaired bile secretion or inadequate absorption of nutrients
Include as part of metabolic or fat balance studies
The xylose absorption tests evaluate carbohydrate absorption by the mucosa of the proximal small intestine. In patients with renal deficiency, rely on the serum test only. In functionally anephric patients, the test is unreliable. Nonfasting serum samples are often compromised by significant analytic interferences.
General References
Borowitz D.Update on the evaluation of pancreatic exocrine status in cystic fibrosis.Curr Opin Pulm Med. 2005;11(6):524-527. (Link to PubMed)
Ehrenpreis ED, Salvino M, Craig RM.Improving the serum D-xylose test for the identification of patients with small intestinal malabsorption.J Clin Gastroenterol. 2001;33(1):36-40. (Link to PubMed)
Ginsburg PM, Janefalkar P, Rubin DT, Ehrenpreis ED.Malabsorption testing: a review.Curr Gastroenterol Rep. 2000;2(5):370-377. (Link to PubMed)
Holbrook I.The British Society of Gastroenterology guidelines for the investigation of chronic diarrhoea, 2nd edition.Ann Clin Biochem. 2005;42(Pt 3):170-174. (Link to PubMed)
Nakamura T, Takeuchi T.Pancreatic steatorrhea, malabsorption, and nutrition biochemistry: a comparison of Japanese, European, and American patients with chronic pancreatitis.Pancreas. 1997;14(4):323-333. (Link to PubMed)
Siegmund E, Lohr JM, Schuff-Werner P.[The diagnostic validity of non-invasive pancreatic function tests--a meta-analysis].Z Gastroenterol. 2004;42(10):1117-1128. (Link to PubMed)
Simadibrata M, Syam AF.Diagnosis and management of chronic diarrhea.Acta Med Indones. 2004;36(4):228-238. (Link to PubMed)
Reviewed by
Grenache, David G., Ph.D. Medical Director, Special Chemistry at ARUP Laboratories; Assistant Professor, Clinical Pathology, University of Utah
Comprehensive Review: July 2008
Last Update: July 2008